[Clinical evaluation of radiosensitizing effects of misonidazole].
D001932:Brain Neoplasms / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004938:Esophageal Neoplasms / Q000532:radiotherapy; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008920:Misonidazole / Q000627:therapeutic use*; D009593:Nitroimidazoles / Q000627:therapeutic use*
D009593:Nitroimidazoles; D008920:Misonidazole